In the present study, we found abnormal expression of LPA receptors in mammary carcinomas, and that LPA2 and LPA3 expression was enhanced in breast cancer compared with normal breast and benign-disease tissues, although the expression level of LPA1 was not significantly different between each subgroup. Here, LPAR2 is linked to breast cancer.